Clinical Trials - VERU

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06282458Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight MgmtCOMPLETEDPHASE22024-04-292025-08-222025-04-11
NCT05079360Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast CancerWITHDRAWNPHASE22023-03-152024-05-262024-03-30
NCT05065411Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast CancerTERMINATEDPHASE32022-04-112024-01-092023-10-19
NCT05008510P2 Clinical Efficacy & Safety Study of V-111 Monotherapy & Sacituzumab Govitecan-hziy/V-111 Combo Therapy for mTNBC .WITHDRAWNPHASE22021-12-302023-06-302022-07-30
NCT04869943Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast CancerTERMINATEDPHASE32021-10-122024-01-092024-01-09
NCT04844749Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting AgentTERMINATEDPHASE32021-06-242023-05-042023-05-04
NCT04843319To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate CancerTERMINATEDPHASE1, PHASE22021-06-092023-01-192023-01-19
NCT04842747VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on StudyCOMPLETEDPHASE32021-05-182022-07-062022-07-06
NCT04388826COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111COMPLETEDPHASE22020-06-182021-08-132020-12-18
NCT03752099To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate CancerTERMINATEDPHASE1, PHASE22019-01-182023-03-152023-03-15
NCT03646162Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate CancerCOMPLETEDPHASE22018-09-142020-10-152020-04-30